Last reviewed · How we verify
ILIT with extract of causal allergen — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
ILIT with extract of causal allergen (ILIT with extract of causal allergen) — Gachon University Gil Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ILIT with extract of causal allergen TARGET | ILIT with extract of causal allergen | Gachon University Gil Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ILIT with extract of causal allergen CI watch — RSS
- ILIT with extract of causal allergen CI watch — Atom
- ILIT with extract of causal allergen CI watch — JSON
- ILIT with extract of causal allergen alone — RSS
Cite this brief
Drug Landscape (2026). ILIT with extract of causal allergen — Competitive Intelligence Brief. https://druglandscape.com/ci/ilit-with-extract-of-causal-allergen. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab